GlassScriptPhysician profile
Wylie Lowery
NPI 1518931948
$3,648.01
in general payments reported to CMS, 2019-2025
12 companies · $278 in 2025
The $278 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $32.89 · 2020: $207 · 2021: $1,468 · 2022: $1,294 · 2023: $96.62 · 2024: $271 · 2025: $278.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $645.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $645.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supreme Orthopedic Systems, LLC | $2,414.69 | 2021-2025 | |
| Zimmer Biomet Holdings, INC. | $410.17 | 2021-2025 | Mymobility Platform |
| Smith+Nephew, INC. | $298.27 | 2020-2025 | Na, Mini-Open Latarjet, Lens 4k |
| Medtronic, INC. | $161.11 | 2021-2024 | Intellis Adaptivestim |
| Innovation Technologies INC | $112.44 | 2020 | |
| Depuy Synthes Sales INC. | $94.36 | 2023-2025 | Rigidfix, Truespan Orthocord, Orthocord |
| Stryker Corporation | $92.39 | 2019-2021 | |
| Fidia Pharma USA INC. | $25.07 | 2025 | Hymovis |
| Pacira Pharmaceuticals Incorporated | $14.32 | 2025 | Exparel |
| Horizon Therapeutics Plc | $14.02 | 2019 | |
| Stimwave Technologies Incorporated | $11.17 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$91,736.40 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wylie Lowery listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.